A comparison of fluorescence in situ hybridization (FISH) and cytogenetics for detection of CSF1 (1p13) rearrangements in tenosynovial giant cell tumors

被引:0
|
作者
Nishio, J. [1 ]
Neff, J. R. [1 ]
Dafferner, A. J. [1 ]
Hartmann, M. M. [1 ]
Zhou, M. [1 ]
Bridge, J. A. [1 ]
机构
[1] Univ Nebraska, Med Ctr, Omaha, NE USA
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2006年 / 8卷 / 05期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:659 / 659
页数:1
相关论文
共 50 条
  • [41] Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors
    Prayson, RA
    Castilla, EA
    Hartke, M
    Pettay, J
    Tubbs, RR
    Barnett, GH
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 512 - 517
  • [42] Detection of Panulirus argus Virus 1 (PaV1) in the Caribbean spiny lobster using fluorescence in situ hybridization (FISH)
    Li, Caiwen
    Shields, Jeffrey D.
    Small, Hamish J.
    Reece, Kimberly S.
    Hartwig, Carmony L.
    Cooper, Roland A.
    Ratzlaff, Robert E.
    DISEASES OF AQUATIC ORGANISMS, 2006, 72 (03) : 185 - 192
  • [43] Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid Tumors
    Heydt, Carina
    Ruesseler, Vanessa
    Pappesch, Roberto
    Wagener, Svenja
    Haak, Anja
    Siebolts, Udo
    Riedel, Richard
    Michels, Sebastian
    Wolf, Juergen
    Schultheis, Anne M.
    Rehker, Jan
    Buettner, Reinhard
    Merkelbach-Bruse, Sabine
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 971 - 984
  • [44] Safety and efficacy with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received no prior antiecolony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study
    Serrano, C.
    Blay, J-Y.
    Rutkowski, P.
    Gelderblom, H.
    Stacchiotti, S.
    Falcon Gonzalez, A.
    Desai, J.
    Le Cesne, A.
    Ferraresi, V.
    Palmerini, E.
    Wilky, B. A.
    Wagner, A. J.
    Bernthal, N. M.
    van de Sande, M.
    Narasimhan, S.
    Harrow, B.
    Sharma, M. G.
    Ruiz-Soto, R.
    Sherman, M. L.
    Tap, W. D.
    ANNALS OF ONCOLOGY, 2024, 35 : S1053 - S1053
  • [45] Fluorescence in situ hybridization (FISH) on touch preparations: A reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors
    Scheie, D
    Andresen, PA
    Cvancarova, M
    Signe, A
    Helseth, E
    Skullerud, K
    Beiske, K
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (07) : 828 - 837
  • [46] Detection of alterations in chromosomes 16 and 1 by fluorescence in situ hybridization in breast tumors cytologically or histologically equivocal for malignancy
    Tsuda, H
    Takarabe, T
    Shimamura, K
    Hirohashi, S
    PATHOBIOLOGY, 1998, 66 (06) : 268 - 273
  • [47] Assignment of the ARAF1 to porcine chromosome Xp11.2-p13 by fluorescence in situ hybridization
    Yasue, H
    Adams, L
    Ozawa, A
    Hanazono, M
    Li, N
    Lin, ZH
    Kusumoto, H
    MAMMALIAN GENOME, 1997, 8 (06) : 457 - 458
  • [48] Assignment of the ARAF1 to porcine Chromosome Xpll.2-p13 by fluorescence in situ hybridization
    Hiroshi Yasue
    L. Adams
    A. Ozawa
    M. Hanazono
    N. Li
    Z. H. Lin
    H. Kusumoto
    Mammalian Genome, 1997, 8 : 457 - 458
  • [49] Detection by fluorescence in situ hybridization of microdeletions at 1p36 in lymphomas, unidentified on cytogenetic analysis
    Rajgopal, A
    Carr, IM
    Leek, JP
    Hodge, D
    Bell, SM
    Roberts, P
    Horgan, K
    Bonthron, DT
    Selby, PJ
    Markham, AF
    MacLennan, KA
    CANCER GENETICS AND CYTOGENETICS, 2003, 142 (01) : 46 - 50
  • [50] Analysis of chromosome 1p abnormalities in renal oncocytomas by loss of heterozygosity studies - Correlation with conventional cytogenetics and fluorescence in situ hybridization
    Picken, Maria M.
    Chyna, Brent
    Flanigan, Robert C.
    Lee, John M.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (03) : 377 - 382